Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography.
about
The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimatesFluorescence-based methods for detecting caries lesions: systematic review, meta-analysis and sources of heterogeneity.Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiativeComparing Diagnostic Techniques of Magnetic Resonance Angiography (MRA) and Doppler Ultrasonography in Determining Severity of Renal Artery StenosisACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.A qualitative study into the difficulties experienced by healthcare decision makers when reading a Cochrane diagnostic test accuracy review.Steady state vascular imaging with extracellular gadobutrol: evaluation of the additional diagnostic benefit in patients who have undergone a peripheral magnetic resonance angiography protocolCurrent approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic reviewEvaluation of meglumine gadoterate-enhanced MR angiography (MRA) compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease: a pooled analysis of data from two clinical trials.Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings.Systematic reviews and meta-analyses for more profitable strategies in peripheral artery diseaseContrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study.Assessment of Carotid Artery Stenosis and the Use of Statins.Variation of a test's sensitivity and specificity with disease prevalence.Whole-body magnetic resonance angiography at 3.0 Tesla.Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.Magnetic resonance angiography: current status in the planning and follow-up of endovascular treatment in lower-limb arterial disease.Time-resolved lower extremity MRA with temporal interpolation and stochastic spiral trajectories: preliminary clinical experience.Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial.Technical considerations for lower limb multidetector computed tomographic angiography.Contrast-enhanced peripheral MRA: technique and contrast agents.Advanced imaging in limb salvage.Patterns of disease distribution of lower extremity peripheral arterial disease.Diagnosis and assessment of peripheral arterial disease in the diabetic foot.Visual Inspection for Caries Detection: A Systematic Review and Meta-analysis.Repeatability of Non-Contrast-Enhanced Lower-Extremity Angiography Using the Flow-Spoiled Fresh Blood Imaging.Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography.Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography.Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: a comparative study versus standard digital angiography.Value of single-dose contrast-enhanced magnetic resonance angiography versus intraarterial digital subtraction angiography in therapy indications in abdominal and iliac arteries.Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression.Evidence of bias and variation in diagnostic accuracy studies.Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.Gadolinium-enhanced off-resonance contrast angiography.Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.Non-contrast-enhanced four-dimensional (4D) intracranial MR angiography: a feasibility study.Ghost magnetic resonance angiography.Prognostic value of lower limb perfusion single-photon emission computed tomography-computed tomography in patients with lower limb atherosclerotic peripheral artery disease.A Factor Increasing Venous Contamination on Bolus Chase Three-dimensional Magnetic Resonance Imaging: Charcot Neuroarthropathy.Recent advances in magnetic resonance imaging for peripheral artery disease.
P2860
Q27025258-68E25D0F-1540-40DF-A9A9-CF283AEB3C88Q27693288-A3D70B58-CA12-4947-A970-7C411F36BC3DQ30447885-4E8244BB-5BD2-4109-9964-FA472EC45524Q30467669-9997ED2D-9F73-4BA4-9B05-7C72A84F0187Q30475186-CF6667B3-7369-48DB-AE31-BEC2073DA5ACQ30540060-8F2ACB92-60B2-44F4-B057-407FD792A8E8Q33588278-3772D0D2-9DDC-4379-90E4-A005035C3B7BQ33743880-E5FF7455-CCC2-4B4D-BDB6-85903F72ABE4Q34100385-E21EDB3E-3E37-46F8-B811-3140D15346B4Q34291246-AE7AA3F0-61DB-42AA-8DC0-240C641E4D09Q34576281-F1591A56-5544-4300-9AB1-6BB31B61837CQ35990353-24E499B6-E1E0-4B89-9F85-DFC993E4E3ACQ36065333-B2B4B956-9447-4830-80B3-CDF89A06AF8CQ37076046-3DC90482-A977-42BF-8834-AA4D17D58F91Q37084569-0A20493B-7FC0-46E9-B7C8-81253211C241Q37321632-4003A569-B707-4DCB-AE63-6EA082DBEFCCQ37364520-F93540CE-0DE8-47E8-A1BB-CE62F5CDA5B1Q37699194-AB57AC22-8107-48A1-B8CE-33C37B3A4A2AQ37761689-C8F2F10A-69E3-47EB-8309-3501F490B536Q37817585-741B1AF1-9854-4030-A13A-E7205D363554Q38030503-F7EAD22D-9708-4711-B6AE-DAB8C6EBB1DAQ38076118-9AD30679-9650-4C11-815C-3F21C0880D37Q38197822-63622012-979E-425E-846F-16935CD0A60CQ38375455-10777768-D7A3-45E2-89AA-4DE72597581BQ38494322-DDC017A5-4B84-4AC7-9FE1-16366A83610FQ38634717-888C29F8-DD5C-424C-AFAC-9E69FAD267A6Q39653597-AA1A9AE8-9FCA-4A04-9EE6-7C40F50C2AD4Q39657877-BDEF3A27-5613-4FEB-A20F-32500CCFF745Q39763647-13CB2F33-027E-4EE7-8DB6-16CE1C60499EQ39785038-8C276627-F261-4F39-9320-D5FF2C6BA8D6Q40105530-76641B82-A3D1-475B-AB57-B7E1B537389CQ42860877-289947C5-6E9D-44AD-BE7C-6E78D244A5D5Q46453502-CF433AB8-6979-496C-8AA9-68A1B4AB33CCQ48916952-6223E052-65A6-41B0-8C12-4C100FCC3EABQ51570082-E4694004-8CB9-4F5B-BA4C-7C061BA1B60BQ51718240-1C655EC6-D207-49D8-80FC-60121AC10853Q51847612-8851DEB5-804D-49FF-9650-D4CE5BACE014Q52957006-89C4C977-C538-4E23-B047-7A658F651FF7Q55008451-A64BF34E-5A1A-4E04-A476-041107E2CED9Q55257450-ACA5B619-8CE6-4EA6-A43E-025385FA4878
P2860
Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Peripheral arterial disease: m ...... performance of MR angiography.
@ast
Peripheral arterial disease: m ...... performance of MR angiography.
@en
Peripheral arterial disease: m ...... performance of MR angiography.
@nl
type
label
Peripheral arterial disease: m ...... performance of MR angiography.
@ast
Peripheral arterial disease: m ...... performance of MR angiography.
@en
Peripheral arterial disease: m ...... performance of MR angiography.
@nl
prefLabel
Peripheral arterial disease: m ...... performance of MR angiography.
@ast
Peripheral arterial disease: m ...... performance of MR angiography.
@en
Peripheral arterial disease: m ...... performance of MR angiography.
@nl
P2093
P1433
P1476
Peripheral arterial disease: m ...... performance of MR angiography.
@en
P2093
Nelemans PJ
van Engelshoven JM
P304
P356
10.1148/RADIOLOGY.217.1.R00OC11105
P407
P577
2000-10-01T00:00:00Z